TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive NCI Seen Shifting Away From Comprehensive Center Emphasis Toward Encouraging Clinical Excellence April 30, 1976
TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
TCL Archive Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues October 8, 1982